Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Head and Neck Neoplasms × cabozantinib × Clear all

Sponsor

Conditions

Prostatic Neoplasms 13 Carcinoma, Renal Cell 12 Neoplasm Metastasis 7 Neoplasms 6 Carcinoma, Hepatocellular 5 Thyroid Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Medullary 4 Breast Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Neuroendocrine Tumors 3 Thyroid Cancer, Papillary 2 Small Cell Lung Carcinoma 2 Recurrence 2 Pain 2 Multiple Myeloma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Astrocytoma 2 Adenoma, Islet Cell 2 Adenocarcinoma, Follicular 2 Adenocarcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1

Interventions

Cisplatin 60 Cetuximab 51 Radiotherapy 34 pembrolizumab 26 Radiotherapy, Intensity-Modulated 23 Carboplatin 21 Docetaxel 19 Paclitaxel 18 Fluorouracil 17 Pemetrexed 9 Erlotinib Hydrochloride 9 Nivolumab 8 Gemcitabine 8 Radiation 7 Drug Therapy 7 Bevacizumab 7 durvalumab 6 Panitumumab 6 Everolimus 6 epacadostat 5 Surgical Procedures, Operative 5 Standard of Care 5 Lapatinib 5 Gefitinib 5 Albumin-Bound Paclitaxel 5 130-nm albumin-bound paclitaxel 5 Oxaliplatin 4 Ipilimumab 4 Cyclophosphamide 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡